Thursday, March 8, 2012

New FDA approved drug to treat infants with respiratory distress syndrome

New FDA approved drug to treat infants with respiratory distress syndrome: Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.

No comments: